Altered intestinal microbial composition (dysbiosis) and metabolic products activate
aggressive mucosal immune responses that mediate inflammatory bowel diseases (IBD) …

Alterations of the gut microbiota may cause dysregulated mucosal immune responses
leading to the onset of inflammatory bowel diseases (IBD) in genetically susceptible hosts …

Inflammatory bowel diseases (IBD), including Crohn's disease, ulcerative colitis, and
pouchitis, are chronic, relapsing intestinal inflammatory disorders mediated by dysregulated …

The inflammatory bowel diseases (IBDs) are chronic inflammatory conditions, which are
increasing in prevalence worldwide. The IBDs are thought to result from an aberrant immune …

Highlights•IBD is characterized by a vicious circle between altered host and microbiota
factors.•The gut microbiota is identified as a new therapeutic and diagnostic …

Inflammatory bowel disease (IBD) is a result of chronic inflammation caused, in some part,
by dysbiosis of intestinal microbiota, mainly commensal bacteria. Gut dysbiosis can be …

Inflammatory bowel diseases (IBD) are chronic relapsing inflammatory disorders involving
the gastrointestinal (GI) tract, which arise from the confluence of genetic, immunological …

Inflammatory bowel disease (IBD) is a multifactorial disease, which is thought to be an
interplay between genetic, environment, microbiota, and immune-mediated factors …

The aetiology of inflammatory bowel disease (IBD) probably involves a combination of
genetic predisposition and environmental factors that may be channelled through an …

Inflammatory bowel disease (IBD) is a chronic, recurrent inflammatory disease of the
gastrointestinal tract. In addition to digestive symptoms, patients with IBD may also develop …